FDA approves COVID-19 booster shot for transplant recipients, other immunocompromised Americans
The Food and Drug Administration on Thursday night gave formal approval for severely immunocompromised Americans to get a third shot of the Pfizer-BioNTech and Moderna COVID-19 vaccines. Studies have shown that transplant recipients and others with seriously weakened immune systems don't get the same level of protection against the coronavirus from the first two doses, but many mount a stronger immune response after a third dose.
"Today's action allows doctors to boost immunity in certain immunocompromised individuals who need extra protection from COVID-19," said Dr. Janet Woodcock, the FDA's acting commissioner. Less than 3 percent of the U.S. population will be approved for the booster shot, and the FDA's statement did not mention immunocompromised people who received the one-dose Johnson & Johnson vaccine. And it isn't clear which high-risk groups would benefit from a booster shot.
"This is all going to be very personalized," said Dr. Dorry Segev, a transplant surgeon at Johns Hopkins University who is conducting a National Institutes of Health study on booster shots for organ transplant recipients. But it's clear the risks are greater for the immunocompromised. One recent study led by Sergev found that vaccinated transplant recipients are 82 times more likely to get a breakthrough COVID-19 infection and 485 times more likely to be hospitalized or die from the coronavirus.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
U.S. health officials are closely monitoring how long the vaccines protect people without suppressed immune systems, with an eye to whether booster shots will eventually be necessary for the general population. Everyone will likely need a booster shot at some point, White House coronavirus adviser Dr. Anthony Fauci said at a briefing Thursday, but "apart from the immunocompromised, we do not believe that others, elderly or non-elderly, need a vaccine at this moment."
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Melting polar ice is messing with global timekeeping
Speed Read Ice loss caused by climate change is slowing the Earth's rotation
By Peter Weber, The Week US Published
-
The Week contest: Stick guitar
Puzzles and Quizzes
By The Week US Published
-
'Sports executives ushered a fox into the henhouse'
Instant Opinion Opinion, comment and editorials of the day
By Harold Maass, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical records
Speed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
By Peter Weber, The Week US Published
-
Afghanistan has a growing female suicide problem
Speed Read The Taliban has steadily whittled away women's and girls' rights in Afghanistan over the past 2 years, prompting a surge in depression and suicide
By Peter Weber, The Week US Published
-
US life expectancy rose in 2022 but not to pre-pandemic levels
Speed Read Life expectancy is slowly crawling back up
By Devika Rao, The Week US Published
-
Vallance diaries: Boris Johnson 'bamboozled' by Covid science
Speed Read Then PM struggled to get his head around key terms and stats, chief scientific advisor claims
By The Week UK Published
-
An increasing number of dog owners are 'vaccine hesitant' about rabies
Speed Read A new survey points to canine vaccine hesitancy
By Devika Rao, The Week US Published
-
Anger may be a powerful motivator for tough goals, new study suggests
Speed Read Keeping your cool might actually be less efficient than letting your anger drive you
By Theara Coleman, The Week US Published
-
A tropical skin disease is making the rounds in the US
Speed Read Leishmaniasis is endemic to the country and can cause ulcers and disfiguration
By Devika Rao, The Week US Published